第 1 到 12 筆結果,共 12 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2023 | Homoharringtonine as a PHGDH inhibitor: Unraveling metabolic dependencies and developing a potent therapeutic strategy for high-risk neuroblastoma | Hsieh, Chiao-Hui; Huang, Chen-Tsung; YI-SHENG CHENG ; Hsu, Chun-Hua; WEN-MING HSU ; Chung, Yun-Hsien; Liu, Yen-Lin; Yang, Tsai-Shan; Chien, Chia-Yu; Lee, Yu-Hsuan; Huang, Hsuan-Cheng; HSUEH-FEN JUAN | Biomedicine & Pharmacotherapy | 0 | 0 | |
2 | 2021 | BI-2536 Promotes Neuroblastoma Cell Death via Minichromosome Maintenance Complex Components 2 and 10 | Hsieh, Chiao-Hui; Yeh, Hsiang-Ning; Huang, Chen-Tsung; Wang, Wei-Hsuan; WEN-MING HSU ; Huang, Hsuan-Cheng; HSUEH-FEN JUAN | Pharmaceuticals (Basel, Switzerland) | 7 | 6 | |
3 | 2019 | Activation of Aryl Hydrocarbon Receptor by Kynurenine Impairs Progression and Metastasis of Neuroblastoma | Wu, Pei-Yi; Yu, I-Shing; Lin, Yueh-Chien; Chang, Yu-Tzu; Chen, Chien-Chin; Lin, Kuan-Hung; Tseng, Tzu-Hsuan; Kargren, Mati; Tai, Yu-Ling; Shen, Tang-Long; Liu, Yen-Lin; Wang, Bo-Jeng; Chang, Chi-Hao; Chen, Wei-Min; Juan, H.-F. ; Huang, Shiu-Feng; Chan, Ya-Yun; Liao, Yung-Feng; WEN-MING HSU ; TANG-LONG SHEN | Cancer research | 29 | 27 | |
4 | 2019 | Therapeutic targeting of non-oncogene dependencies in high-risk neuroblastoma | Huang, C.-T.; Hsieh, C.-H.; Lee, W.-C.; Liu, Y.-L.; Yang, T.-S.; WEN-MING HSU ; Oyang, Yen-Jen ; Huang, H.-C.; HSUEH-FEN JUAN | Clinical Cancer Research | 15 | 14 | |
5 | 2017 | A multidisciplinary team care approach improves outcomes in high-risk pediatric neuroblastoma patients | HSIU-HAO CHANG ; Liu, Yen-Lin; MENG-YAO LU ; SHIANN-TANG JOU ; YUNG-LI YANG ; Lin, Dong-Tsamn; Lin, Kai-Hsin; KAI-YUAN TZEN ; RUOH-FANG YEN ; CHING-CHU LU ; CHIA-JU LIU ; STEVEN SHINN-FORNG PENG ; YUNG-MING JENG ; Huang, Shiu-Feng; HSIN-YU LEE ; Juan, Hsueh-Fen ; MIN-CHUAN HUANG ; Liao, Yung-Feng; Lee, Ya-Ling; WEN-MING HSU | Oncotarget | 16 | 14 | |
6 | 2016 | Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data | CHIA-LANG HSU ; Chang, H.-Y.; Chang, J.-Y.; WEN-MING HSU ; Huang, H.-C.; Juan, H.-F. | Oncotarget | 32 | 29 | |
7 | 2014 | Aryl hydrocarbon receptor downregulates MYCN expression and promotes cell differentiation of neuroblastoma | HSUEH-FEN JUAN ; WEN-MING HSU ; HSIN-YU LEE ; YUNG-MING JENG ; Wang B.-J.; Lu Y.-L.; Yu I.-S.; Shih Y.-Y.; Lee H. | PLoS ONE | 33 | 32 | |
8 | 2012 | Calreticulin mediates nerve growth factor-induced neuronal differentiation | Shih Y.-Y.; Nakagawara A.; HSIN-YU LEE ; Juan H.-F.; YUNG-MING JENG ; Lin D.-T.; YUNG-LI YANG ; Tsay Y.-G.; MIN-CHUAN HUANG ; CHIEN-YUAN PAN ; WEN-MING HSU ; HSUEH-FEN JUAN | Journal of Molecular Neuroscience | 15 | 16 | |
9 | 2011 | Nuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastoma | YU-YIN SHIH; HSIN-YU LEE ; Nakagawara, Akira; HSUEH-FEN JUAN ; YUNG-MING JENG ; Tsay, Yeou-Guang; DONG-TSAMN LIN ; FON-JOU HSIEH ; CHIEN-YUAN PAN ; WEN-MING HSU ; Liao Y.-F. | PLoS ONE | 23 | 21 | |
10 | 2011 | Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma | Chen S.-T.; YUNG-MING JENG ; Chang C.-C.; HSIU-HAO CHANG ; MIN-CHUAN HUANG ; Juan H.-F.; Hsu C.-H.; Lee H.; Liao Y.-F.; Lee Y.-L.; WEN-MING HSU ; HSUEH-FEN JUAN | Cancer Science | 21 | 20 | |
11 | 2010 | Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma | HSIU-HAO CHANG ; HSIN-YU LEE ; Hu M.-K.; PO-NIEN TSAO ; Juan H.-F.; MIN-CHUAN HUANG ; Shih Y.-Y.; Wang B.-J.; YUNG-MING JENG ; Chang C.L.; Huang S.-F.; Tsay Y.-G.; FON-JOU HSIEH ; Lin K.-H.; WEN-MING HSU ; HSUEH-FEN JUAN | Clinical Cancer Research | 43 | 42 | |
12 | 2008 | Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis | WEN-MING HSU ; HSIN-YU LEE ; HSUEH-FEN JUAN ; Shih Y.-Y.; Wang B.-J.; CHIEN-YUAN PAN ; YUNG-MING JENG ; HSIU-HAO CHANG ; MENG-YAO LU ; Lin K.-H.; HONG-SHIEE LAI ; Chen W.-J.; Tsay Y.-G.; Liao Y.-F.; FON-JOU HSIEH | Clinical Cancer Research | 28 | 26 |